PCVX

Vaxcyte, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Wassil JimCHIEF OPERATING OFFICER
$128k2.3k shares
SellMay 1, 2026
$56.83
--
Cowan ElviaSVP, Finance & CAO
$180k3k shares
SellApr 7, 2026
$60.00
--
Wassil JimCHIEF OPERATING OFFICER
$82k1.4k shares
SellApr 1, 2026
$58.14
--
Wassil JimCHIEF OPERATING OFFICER
$49k838 shares
SellApr 1, 2026
$58.93
--
Cowan ElviaSVP, Finance & CAO
$82k1.5k shares
SellMar 17, 2026
$55.39
--
Cowan ElviaSVP, Finance & CAO
$23k405 shares
SellMar 17, 2026
$56.26
--

News

globenewswire.comVaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adultsglobenewswire.comJun 2seekingalpha.comVaxcyte, Inc. (PCVX) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.comMay 12globenewswire.comVaxcyte Reports First Quarter 2026 Financial Results and Provides Business Updateglobenewswire.comMay 6seekingalpha.comVaxcyte's Manufacturing-Backed Vaccine Platform Is Redefining The PCV Marketseekingalpha.comMay 1globenewswire.comVaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conferenceglobenewswire.comApr 7